If left untreated, it can lead to Heart palpitations and shortness of breath Weakness, tiredness, or lightheadedness Pale skin Vision loss Constipation, diarrhea, loss of appetite, or gas A smooth tongue Depression Memory loss Behavioral changes Numbness or tingling Muscle weakness Problems walking not trying to give you the wobbles here!), low levels of B12 can be linked to the development of pernicious anemia, dementia, or osteoporosis
Another option is to try a different GLP-1 receptor agonist to help with weight loss
The calculator uses the concentration entered in mg/mL and the selected dose in mg to estimate injection volume and U-100 syringe units
Understanding the science behind medication timing helps you maximize results with your personalized GLP-1 therapy
This review may provide a background to guide future research about the cellular mechanisms of GLP-1-induced feeding inhibition
Clinical trials show tirzepatide producing slightly greater average weight loss, with participants losing 15 to 21 percent of body weight compared to 15 to 17 percent with semaglutide
